Cite
HARVARD Citation
Stenzl, A. et al. (n.d.). 853PARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of high and low disease volume and risk groups. Annals of oncology. p. . [Online].